Skip to main content
Atrás
VTRLY logo

Vitrolife AB (publ)

Calidad de datos: 100%
VTRLY
OTC Healthcare Medical - Devices
$11.00
$0.00 (0.00%)
Cap. Mercado: 1.49B
Rango del Día
$11.00 $11.00
Rango de 52 Semanas
$9.50 $18.55
Volumen
130
Promedio 50D / 200D
$12.38 / $14.80
Cierre Anterior
$11.00

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E -0.3 0.3
P/B 0.2 2.9
ROE % -46.6 3.7
Net Margin % -155.0 3.8
Rev Growth 5Y % 17.8 10.0
D/E 0.2 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 $0.00
$0.00 – $0.00
 3.9 B 0
FY2026 $0.00
$0.00 – $0.00
 3.6 B 0

Puntos Clave

Revenue grew 17.77% annually over 5 years — strong growth
Earnings declined -1077.00% over the past year
Debt/Equity of 0.20 — conservative balance sheet
Generating 343.10M in free cash flow
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 28.17%

Crecimiento

Revenue Growth (5Y)
17.77%
Revenue (1Y)-10.40%
Earnings (1Y)-1077.00%
FCF Growth (3Y)-26.67%

Calidad

Return on Equity
-46.55%
ROIC4.57%
Net Margin-155.00%
Op. Margin17.91%

Seguridad

Debt / Equity
0.20
Current Ratio3.40
Interest Coverage12.08

Valoración

P/E Ratio
-0.30
P/B Ratio0.19
EV/EBITDA3.95
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -10.40% Revenue Growth (3Y) -4.05%
Earnings Growth (1Y) -1077.00% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 17.77% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.23B Net Income (TTM) -5.01B
ROE -46.55% ROA -45.06%
Gross Margin 61.76% Operating Margin 17.91%
Net Margin -155.00% Free Cash Flow (TTM) 343.10M
ROIC 4.57% FCF Growth (3Y) -26.67%
Safety
Debt / Equity 0.20 Current Ratio 3.40
Interest Coverage 12.08 Dividend Yield 0.01%
Valuation
P/E Ratio -0.30 P/B Ratio 0.19
P/S Ratio 0.46 PEG Ratio 0.00
EV/EBITDA 3.95 Dividend Yield 0.01%
Market Cap 1.49B Enterprise Value 2.29B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.23B 3.61B 3.51B 3.23B 1.68B
Net Income -5.01B 513.00M -3.85B 394.00M 341.00M
EPS (Diluted) -34.79 3.78 -28.44 2.91 2.97
Gross Profit 2.00B 2.14B 1.98B 1.78B 1.05B
Operating Income 579.03M 783.00M -3.59B 654.00M 435.38M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 11.12B 17.45B 16.33B 20.55B 19.43B
Total Liabilities 3.23B 3.81B 3.61B 3.81B 4.09B
Shareholders' Equity 7.89B 13.64B 12.72B 16.74B 15.32B
Total Debt 1.61B 2.09B 2.09B 2.23B 2.48B
Cash & Equivalents 809.00M 1.14B 861.00M 578.00M 630.09M
Current Assets 2.09B 2.36B 1.91B 1.57B 1.41B
Current Liabilities 615.00M 705.00M 557.00M 621.00M 954.33M

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#413 of 825
42

Actividad Reciente

Entró Deep Value Investing (Seth Klarman)
Mar 24, 2026